Profile data is unavailable for this security.
About the company
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD., formerly Hubei Hongcheng General Machinery Co., Ltd., is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company's products include heat-clearing and detoxifying series, digestive system series, pediatric series, breathing series, cardiovascular series and gynecology series. Its pharmaceuticals consist of tablets, mixtures, injections, capsules, granules and sprays, among others. The Company mainly distributes its products within domestic markets.
- Revenue in CNY (TTM)9.67bn
- Net income in CNY2.99bn
- Incorporated1997
- Employees5.23k
- LocationHubei Jumpcan Pharmaceutical Co LtdBaotawan, Daqing West Road, Taixing CityTAIZHOU 225441ChinaCHN
- Phone+86 52 389719161
- Fax+86 52 389719009
- Websitehttps://www.jumpcan.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gan & Lee Pharmaceuticals | 2.61bn | 386.85m | 28.76bn | 4.48k | 72.07 | 2.63 | -- | 11.02 | 0.6716 | 0.6716 | 4.52 | 18.38 | 0.234 | 0.8926 | 10.97 | 582,412.30 | 3.47 | 8.30 | 3.71 | 8.83 | 72.29 | 85.39 | 14.83 | 26.44 | 7.74 | -- | 0.0006 | 13.65 | 52.31 | 1.78 | 177.37 | -18.30 | 1.50 | -- |
| Autobio Diagnostics Co Ltd | 4.50bn | 1.30bn | 30.97bn | 5.54k | 23.61 | 3.50 | -- | 6.89 | 2.24 | 2.24 | 7.74 | 15.11 | 0.4066 | 2.08 | 4.27 | 811,768.30 | 11.81 | 12.59 | 14.50 | 15.79 | 64.76 | 61.62 | 29.04 | 26.96 | 2.81 | -- | 0.1035 | 46.40 | 0.0457 | 18.15 | 4.28 | 16.70 | 17.03 | 11.28 |
| Humanwell Healthcare Group Co Ltd | 24.67bn | 1.96bn | 33.56bn | 17.68k | 17.04 | 1.92 | -- | 1.36 | 1.21 | 1.21 | 15.25 | 10.73 | 0.6833 | 3.80 | 2.77 | 1,395,473.00 | 7.21 | 6.20 | 13.29 | 12.72 | 45.02 | 42.82 | 10.55 | 9.84 | 1.20 | 31.56 | 0.3293 | 18.87 | 9.79 | 5.65 | -14.07 | -- | 8.25 | -- |
| Tianjin Pharmcetl Da Ren Tang Grp Cp Ltd | 8.15bn | 973.25m | 33.65bn | 4.62k | 28.29 | 3.94 | -- | 4.13 | 1.27 | 1.27 | 10.60 | 9.09 | 0.744 | 3.12 | 3.24 | 1,765,208.00 | 8.71 | 8.96 | 13.06 | 12.80 | 43.68 | 40.82 | 11.70 | 10.67 | 1.62 | -- | 0.1381 | 56.93 | -0.3266 | 5.28 | 14.49 | 11.93 | -4.33 | 42.22 |
| Hubei Jumpcan Pharmaceutical Co Ltd | 9.67bn | 2.99bn | 36.51bn | 5.23k | 12.15 | 2.55 | -- | 3.78 | 3.26 | 3.26 | 10.54 | 15.51 | 0.5504 | 3.66 | 4.60 | 1,848,716.00 | 17.05 | 16.23 | 22.52 | 20.88 | 79.76 | 82.64 | 30.98 | 24.42 | 3.01 | -- | 0.1275 | 41.76 | 7.32 | 6.02 | 30.04 | 10.83 | -14.70 | 1.11 |
Data as of May 21 2024. Currency figures normalised to Hubei Jumpcan Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
4.85%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Allianz Global Investors Asia Pacific Ltd.as of 30 Apr 2024 | 6.50m | 0.71% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 5.73m | 0.63% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2023 | 5.32m | 0.58% |
| Ping An Fund Management Co., Ltd.as of 30 Sep 2023 | 4.67m | 0.51% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 4.38m | 0.48% |
| Everbright PGIM Fund Management Co. Ltd.as of 31 Dec 2023 | 3.87m | 0.42% |
| China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 3.79m | 0.41% |
| HuaAn Fund Management Co., Ltd.as of 31 Dec 2023 | 3.77m | 0.41% |
| Rongtong Fund Management Co., Ltd.as of 31 Dec 2023 | 3.35m | 0.37% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 31 Dec 2023 | 3.02m | 0.33% |
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
